Epzicom and Dysstasia - a phase IV clinical study of FDA data

Summary:

Dysstasia is reported as a side effect among people who take Epzicom (abacavir sulfate; lamivudine), especially for people who are male, 50-59 old, also take Truvada, and have High blood cholesterol.

The phase IV clinical study analyzes which people have Dysstasia when taking Epzicom. It is created by eHealthMe based on reports of 4,877 people who have side effects when taking Epzicom from the FDA, and is updated regularly.

What is Epzicom?

Epzicom has active ingredients of abacavir sulfate; lamivudine. It is often used in hiv infection. eHealthMe is studying from 4,937 Epzicom users. Check the latest studies of Epzicom.

What is Dysstasia?

Dysstasia (difficulty in standing) is found to be associated with 1,376 drugs and 1,370 conditions by eHealthMe. Check the latest studies of Dysstasia.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 28, 2026

4,877 people reported to have side effects when taking Epzicom.
Among them, 39 people (0.8%) have Dysstasia.

Among these 39 people:

What is the gender of people who have Dysstasia when taking Epzicom? *

female: 35.9 %
male: 64.1 %

What is the age of people who have Dysstasia when taking Epzicom? *

What are other drugs people take besides Epzicom? *

What are other side effects people have besides Dysstasia? *

Pain: 38 people, 97.44%
Emotional Distress: 38 people, 97.44%
Stress And Anxiety: 36 people, 92.31%
Anhedonia (inability to experience pleasure from activities usually found enjoyable): 33 people, 84.62%
Gait Disturbance: 29 people, 74.36%
Chronic Kidney Disease: 22 people, 56.41%
Acute Kidney Failure: 21 people, 53.85%
Bone Density Decreased: 17 people, 43.59%
Osteoporosis (bones weak and more likely to break): 17 people, 43.59%
Renal Impairment (severely reduced kidney function): 14 people, 35.90%

What are the existing conditions these people have? *

High Blood Cholesterol: 2 people, 5.13%

* Approximation only. Some reports may have incomplete information.

Do you take Epzicom and have Dysstasia?

- Check whether Dysstasia is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Epzicom:

Epzicom (4,937 reports)

Dysstasia treatments and more:

Dysstasia (35,077 reports)

Browse all side effects of Epzicom:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Dysstasia:

Dysstasia (1,376 drugs)

Browse all the conditions that are associated with Dysstasia:

Dysstasia (1,370 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on abacavir sulfate; lamivudine (the active ingredients of Epzicom) and Epzicom (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.